| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1949656 | Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2010 | 7 Pages |
Abstract
Essential fatty acids (EFA) play a critical role in the brain and regulate many of the processes altered in Alzheimer's disease (AD). Technical advances are allowing for the dissection of complex lipid pathways in normal and diseased states. Arachidonic acid (AA) and specific isoforms of phospholipase A2 (PLA2) appear to be critical mediators in amyloid-β (Aβ)-induced pathogenesis, leading to learning, memory, and behavioral impairments in mouse models of AD. These findings and ongoing research into lipid biology in AD and related disorders promise to reveal new pharmacological targets that may lead to better treatments for these devastating conditions.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Rene O. Sanchez-Mejia, Lennart Mucke,